Signs and Symptoms Associated with Epi-Retinal Membranes

Overview

About this study

The aim of this study is to determine which clinical characteristics are associated with diplopia in patients with epiretinal membranes. 

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Diagnosis of ERM by retina specialist

Exclusion Criteria:

  • None

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 10/24/2024. Questions regarding updates should be directed to the study team contact.
 

 

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Erick Bothun, M.D.

Closed for enrollment

Contact information:

Suzanne Wernimont CCRP

(507) 266-4326

Wernimont.Suzanne@mayo.edu

More information

Publications

Publications are currently not available
.
CLS-20304386

Mayo Clinic Footer